Home > Healthcare > Drug Device Combination > Drug Filled Devices > Contraceptives Market

Contraceptives Market Trends

Report ID: GMI430
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Contraceptives Market Trends

The growing inclination toward planned delayed pregnancy is facilitating the market expansion. This surging inclination is leading to advancements in contraceptives for better efficiency and safety of the patient. The rising adolescent female population worldwide needs easy access for the use of contraceptives that include drugs and devices to avoid problems such as unsafe abortions, unwanted pregnancies, etc.

Factors such as higher education levels, career aspirations, financial stability, and a desire for personal fulfillment are leading to a growing preference for planned and delayed pregnancies. This demographic trend drives the demand for effective contraceptives, as individuals seek reliable methods to prevent unintended pregnancies during their chosen period of delay.
Increased awareness and access to comprehensive sexual education have played a significant role in promoting the importance of family planning and responsible reproductive health practices.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Contraceptives industry size was USD 21.5 billion in 2022 and is expected to reach USD 39.8 billion by 2032 due to the increasing prevalence of unwanted pregnancies, sexually transmitted ailments, technological advancements, and surging awareness related to sexual health worldwide.

Contraceptives industry from the devices segment will register 7.3% CAGR from 2023 to 2032 on account of its high effectiveness in preventing unintended pregnancies and wide range of options such as, condoms, diaphragms, contraceptive sponges, vaginal rings, etc.

North America held 33% share of the contraceptives industry in 2022 and is expected to register a significant CAGR from 2023-2032 owing to the increasing awareness of novel contraceptives comprising pills and devices in the region.

Allergan Plc, Bayer Corporation, Cooper Surgical, Inc, Church & Dwight Co , Inc., Mayer Laboratories, Inc., Merck & Co Inc., Pfizer, and Reckitt Benckiser Group Plc, are some of the major contraceptives companies worldwide.